[1]
|
Corwin, M.T., Lee, A.Y., et al. (2017) Nonstandardized Terminology to Describe Focal Liver Lesions in Patients at Risk for Hepatocellular Carcinoma: Implications Regarding Clinical Communication. American Journal of Roentgenology, 210, 85-90. https://doi.org/10.2214/AJR.17.18416
|
[2]
|
Ao, L., Song, X.K., Li, X.Y., Tong, M.S., et al. (2016) An Individualized Prognostic Signature and Multi-Omics Distinction for Early Stage Hepatocellular Carcinomapatients with Surgical Resection. Oncotarget, 7, 24097-24110.
https://doi.org/10.18632/oncotarget.8212
|
[3]
|
Johnson, P.J., Berhane, S., Kagebayashi, C., Satomura, S., Teng, M., et al. (2014) Assessment of Liver Function in Patients with Hepatocellular Carcinoma: A New Evidence-Based Ap-proach—The ALBI Grade. Journal of Clinical Oncology, 33, 550-558. https://doi.org/10.1200/JCO.2014.57.9151
|
[4]
|
Chen, R.C., Cai, Y.J., Wu, J.M., Wang, X.D., Song, M., et al. (2016) Usefulness of Albumin-Bilirubin Grade for Evaluation of Long-Term Prognosis for Hepatitis B-Related Cirrho-sis. Journal of Viral Hepatitis, 24, 238-245.
https://doi.org/10.1111/jvh.12638
|
[5]
|
Cho, W.R., Hung, C.H., Chen, C.H., Lin, C.C., Wang, C.C., et al. (2020) Ability of the Post-Operative ALBI Grade to Predict the Outcomes of Hepatocellular Carcinoma after Curative Surgery. Scientific Reports, 10, Article No. 7290.
https://doi.org/10.1038/s41598-020-64354-0
|
[6]
|
Chan, A.W.H., Kumada, T., Toyoda, H., Tada, T., Chong, C.C.N., et al. (2016) Integration of Albumin-Bilirubin (ALBI) Score into Barcelona Clinic Liver Cancer (BCLC) System for Hepatocellular Carcinoma. Journal of Gastroenterology and Hepatology, 31, 1300-1306. https://doi.org/10.1111/jgh.13291
|
[7]
|
Chan, A.W.H., Leung, H.H.W., Chong, C.C.N. and Chan, S.L. (2016) Validating the ALBI Grade: Its Current and Future Use in HCC Prognostication. Journal of Hepatology, 66, 661-663. https://doi.org/10.1016/j.jhep.2016.10.037
|
[8]
|
Cucchetti, A., Ercolani, G., Vivarelli, M., Cescon, M., Ravaioli, M., et al. (2009) Is Portal Hypertension a Contraindication to Hepatic Resection? Annals of Surgery, 250, 922-928. https://doi.org/10.1097/SLA.0b013e3181b977a5
|
[9]
|
Takemura, N., Takemura, N., Aoki, T., Hasegawa, K., Kaneko, J., et al. (2019) Hepatectomy for Hepatocellular Carcinoma after Perioperative Management of Portal Hyperten-sion. The British Journal of Surgery, 106, 1066-1074.
https://doi.org/10.1002/bjs.11153
|
[10]
|
Sonohara, F., Yamada, S., Tanaka, N., Tashiro, M., Sunagawa, Y., et al. (2019) Comparison of Non-Invasive Liver Reserve and Fibrosis Models: Implications for Surgery and Prognosis for Hepatocellular Carcinoma. Hepatology Research: The Official Journal of the Japan Society of Hepatology, 49, 1305-1315. https://doi.org/10.1111/hepr.13400
|
[11]
|
Wang, Z.X., Wang, Z.X., Peng, W., Zhang, X.Y., Wen, T.F., et al. (2021) Prognostic Significance of Postoperative Change of PALBI Grade for Patients with Hepatocellular Carci-noma after Hepatectomy. Medicine, 100, e24476.
https://doi.org/10.1097/MD.0000000000024476
|
[12]
|
Zou, H., Wen, Y., Yuan, K., Miao, X.Y., Xiong, L., et al. (2017) Combining Albumin-Bilirubin Score with Future Liver Remnant Predicts Post-Hepatectomy Liver Failure in HBV-Associated HCC Patients. Liver International, 38, 494-502.
https://doi.org/10.1111/liv.13514
|
[13]
|
Kokudo, T., Kokudo, T., Hasegawa, K., Amikura, K., Uldry, E., et al. (2016) Assessment of Preoperative Liver Function in Patients with Hepatocellular Carcinoma—The Albumin-Indocyanine Green Evaluation (ALICE) Grade. PLOS ONE, 11, e0159530. https://doi.org/10.1371/journal.pone.0159530
|
[14]
|
Russolillo, N., Forchino, F., Conci, S., Mele, C., Langella, S., et al. (2019) Validation of the Albumin-Indocyanine Green Evaluation Model in Patients with Resected Hepatocellular Car-cinoma and Comparison with the Albumin-Bili- rubin Score. Journal of Hepato-Biliary-Pancreatic Sciences, 26, 51-57. https://doi.org/10.1002/jhbp.597
|
[15]
|
Hiraoka, A., Kumada, T., Kudo, M., Hirooka, M., Tsuji, K., et al. (2017) Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications. Liver Cancer, 6, 204-215. https://doi.org/10.1159/000452846
|
[16]
|
Wang, Y.K., Bi, X.Y., Li, Z.Y., Zhao, H. and Zhao, J.J. (2017) A New Prognostic Score System of Hepatocellular Carcinoma following Hepatectomy. Chinese Journal of Oncology, 39, 903-909. (In Chinese)
|
[17]
|
Ridker, P.M., Howard, C.P., Walter, V., Everett, B., Libby, P., et al. (2012) Effects of Inter-leukin-1β Inhibition with Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen: A Phase IIb Randomized, Placebo-Controlled Trial. Circulation, 126, 2739-2748.
https://doi.org/10.1161/CIRCULATIONAHA.112.122556
|
[18]
|
刘益民, 贾坤林, 徐翠容, 蒋叙川, 赖永才. 血清白蛋白、前白蛋白水平对非小细胞肺癌患者预后的影响[J]. 标记免疫分析与临床, 2018, 25(2): 232-235.
|
[19]
|
Zhang, L., Chen, Q.G., Li, S.Q., Zhang, J., Min, Q.H., et al. (2018) Preoperative Fibrinogen to Prealbu-min Ratio as a Novel Predictor for Clinical Outcome of Hepatocellular Carcinoma. Future Oncology, 15, 13-22.
https://doi.org/10.2217/fon-2018-0376
|
[20]
|
范龙飞, 刘双池, 段家康, 秦中强, 谈燚. 甲胎蛋白联合纤维蛋白原与白蛋白比值评分系统在肝细胞癌预后中的应用价值[J]. 牡丹江医学院学报, 2020, 41(4): 10-14. https://doi.org/10.13799/j.cnki.mdjyxyxb.2020.04.003
|
[21]
|
Wai, C.T., Greenson, J.K., Fontana, R.J., Kalbfleisch, J.D., Marrero, J.A., et al. (2003) A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Pa-tients with Chronic Hepatitis C. Hepatology, 38, 518-526.
https://doi.org/10.1053/jhep.2003.50346
|
[22]
|
Raftopoulos, S.C., George, J., Bourliere, M., Rossi, E., de Boer, W.B., et al. (2011) Comparison of Noninvasive Models of Fibrosis in Chronic Hepatitis B. Hepatology International, 6, 457-467.
https://doi.org/10.1007/s12072-011-9296-5
|
[23]
|
麦荣云, 曾洁, 叶甲舟, 等. 术前天冬氨酸转氨酶与血小板比值指数预测原发性肝癌肝切除术后肝衰竭的价值[J]. 第二军医大学学报, 2019, 40(1): 61-67. https://doi.org/10.16781/j.0258-879x.2019.01.0061
|
[24]
|
王越, 刘学民, 王博, 等. 术前天冬氨酸转氨酶/血小板比值指数对肝细胞癌患者手术切除后并发症的预测价值[J]. 中华肝胆外科杂志, 2016, 22(5): 289-293. https://doi.org/10.3760/cma.j.issn.1007-8118.2016.05.001
|
[25]
|
Cheng, J.W., Zhao, P., Liu, J.B., Liu, X. and Wu, X.L. (2016) Preoperative Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) Is a Predictor on Postoperative Outcomes of Hepatocellular Carcinoma. Medicine, 95, e5486
https://doi.org/10.1097/MD.0000000000005486
|